Covid vaccines: Will drug companies make bumper profits?

Firms that began work on vaccines for other diseases such as Zika and Sars had their fingers burnt. On the other hand, the market for flu’ jabs, which is worth several billion dollars a year, suggests that if Covid-19, like flu, is here to stay and requires annual booster jabs, then it could be profitable for the firms that come up with the most effective, and most cost-effective products.

Recent Posts

Covid: US opens up to fully vaccinated EU and UK passengers

One British official told the BBC that the decision had come completely out of the blue. Prime Minister Boris Johnson had been planning to raise it on Tuesday in his meeting in the White House with the president, but with little hope of making progress, the official...

read more

Gas crisis: Pig farmers fear they may have to cull animals

Richard Walker, managing director of Iceland, said: "We're now as a business building up our stocks on key lines like frozen meat just to make sure we can deal with any unforeseen issues. But at the moment we're fully stocked, our suppliers are OK, but we do need this...

read more